This document outlines an exclusive GP-led secondary deal for Project Klein, expected to close in June 2018. The investment involves a mid-market buyout strategy focusing on Europe/UK, with key assets including a UK premium distributor, a network of UK medical and cosmetics clinics, an Italian digital marketing company, and a management consulting company. The deal is characterized by a discount to NAV at close of over 5%, a gross multiple of 1.1x, and 80% funding at close. Glendower Capital retains discretion on the use of follow-on capital.
doj/DataSet10/EFTA01389964.pdf
{"title":"SOF IV — Project Klein","key_people":["Glendower Team"],"document_date":"June 2018","document_type":"financial","key_locations":["Europe","UK","Italy"],"document_subtype":"investment summary","key_organizations":["Glendower Capital"],"reference_numbers":["DB-SDNY-0094332","SDNY_GM_00240516","EFTA01389964"]}